Seizure susceptibility after depletion of spinal or cerebellar noradrenaline with 6-OHDA.
D000818:Animals; D002531:Cerebellum / Q000187:drug effects / Q000378:metabolism*; D003292:Convulsants / Q000494:pharmacology; D004597:Electroshock; D006892:Hydroxydopamines / Q000494:pharmacology*; D007276:Injections, Intraventricular; D008297:Male; D008526:Medulla Oblongata / Q000187:drug effects; D009638:Norepinephrine / Q000378:metabolism*; D051381:Rats; D012640:Seizures / Q000139:chemically induced* / Q000378:metabolism; D013116:Spinal Cord / Q000187:drug effects / Q000378:metabolism*
D003292:Convulsants; D006892:Hydroxydopamines; D009638:Norepinephrine